Lucid Diagnostics (LUCD) Change in Accured Expenses (2020 - 2026)
Lucid Diagnostics' (LUCD) quarterly Change in Accured Expenses came in at -$519000.0 in Q1 2026, up 31.35% YoY from -$395129.9 in Q1 2025, and down 217.16% on a QoQ basis from $443000.0 in Q4 2025.
Lucid Diagnostics (LUCD) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 7 years of Change in Accured Expenses data on file, last reported at -$519000.0 in Q1 2026.
- Quarterly Change in Accured Expenses rose 31.35% year-over-year to -$519000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $127000.0 (down 87.61% YoY) and the FY2025 annual result came in at -$110000.0, up 89.13% from the prior year.
- Change in Accured Expenses retreated to -$519000.0 in Q1 2026, from $443000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $7.7 million in Q4 2022 to a low of -$3.5 million in Q3 2024.
- A 5-year average of $612411.8 and a median of $113000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses surged 2260.18% — and 2024, when it sank 750.85%.
- Tracing LUCD's Change in Accured Expenses over 5 years: stood at $7.7 million in 2022, then tumbled by 112.36% to -$946000.0 in 2023, then jumped by 480.44% to $3.6 million in 2024, then plunged by 87.69% to $443000.0 in 2025, then tumbled by 217.16% to -$519000.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$519000.0 (Q1 2026), $443000.0 (Q4 2025), and -$569000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Lucid Diagnostics | 176.04 Mn | 142.63 Mn | 55,000.00 | 243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 243,000.00 |
| Jun 30, 2026 | 243,000.00 |
| Mar 31, 2026 | -519,000.00 |
| Mar 31, 2026 | -519,000.00 |
| Dec 31, 2025 | 443,000.00 |
| Dec 31, 2025 | 443,000.00 |
| Sep 30, 2025 | -569,000.00 |
| Sep 30, 2025 | -569,000.00 |
| Jun 30, 2025 | 772,000.00 |
| Jun 30, 2025 | 772,000.00 |
| Mar 31, 2025 | -756,000.00 |
| Mar 31, 2025 | -756,000.00 |
| Dec 31, 2024 | 3.60 Mn |
| Dec 31, 2024 | 3.60 Mn |
| Sep 30, 2024 | -3.50 Mn |
| Sep 30, 2024 | -3.50 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | -2.79 Mn |
| Mar 31, 2024 | -2.79 Mn |